DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Pronged attack on Fast-Growing lymphomas enters patient testing
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug, epcoritamab, to a standard chemotherapy regimen (called EPOCH-R) is safe and more effective for treating aggressive B-cell lymphomas. The trial will enroll about 18 adults who have not yet received treatment for their…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test 'Ready-Made' immune cell therapy for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a new type of cancer treatment called P-CD19CD20-ALLO1 in adults with specific B-cell lymphomas that have come back or not responded to standard therapies. The treatment involves giving patients a single infusion of specially engine…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists test powerful new drug cocktail in fight against Fast-Growing lymphoma
Disease control Recruiting nowThis early-stage study is testing the safety of adding one or two new targeted drugs to a standard chemotherapy regimen for people with untreated, aggressive B-cell lymphoma. The goal is to see if the new combinations are safe and tolerable for patients. Researchers will enroll a…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE1 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for Tough-to-Treat lymphoma: trial tests Next-Gen cell therapy
Disease control Recruiting nowThis trial is testing a new, experimental CAR-T cell therapy called WZTL-002 for people with aggressive large B-cell lymphoma that has returned or not responded to standard chemotherapy. The main goals are to see how well the therapy works to eliminate the cancer and to understan…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: Malaghan Institute of Medical Research • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Blood test could spare lymphoma patients from unneeded chemo
Disease control Recruiting nowThis study is testing if a special blood test can help doctors personalize treatment for a common type of lymphoma called DLBCL. The goal is to see if patients who show no signs of cancer in their blood halfway through standard chemotherapy can safely stop the chemo drugs early a…
Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA, NOT OTHERWISE SPECIFIED
Phase: NA • Sponsor: Hua-Jay J Cherng, MD • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC